Page 88 - Interactive Theoritical Notes of Bioharmaceutics and pharamcokinetics.docx compressed
P. 88

PharmD clinical pharmacy program            Level 3, Semester 2          Biopharmaceutics & Pharmacokinetics (PT608(

                  2.  Carrier-Mediated Transport

                           A. Active Transport

                           B. Facilitated Diffusion
                           C. Carrier-Mediated Intestinal Transport

                  A.  Active Transport

                      ➢  Active  transport  is  a  carrier-mediated  transmembrane  process  that  plays  an
                         important role in the GI absorption and both of renal and biliary secretion of


                         many drugs and metabolites.
                      ➢  A carrier or membrane transporter binds to the drug and transports it across the


                         membrane.

                  Active transport is characterized by:

                    Molecules can be transferred from a region of low concentration to one of higher

                   concentration (i.e. against a concentration gradient)


                   Therefore, energy is needed which arises from the hydrolysis of ATP or from the

                   transmembrane sodium gradient and/or electrical potential.

                     It is a specialized process requiring a carrier that binds the drug to form a carrier–

                       drug complex that transfers the drug across the membrane and then dissociates

                       the drug on the other side of the membrane. The carrier molecule may be highly

                       selective for the drug molecule.

                     If  the  drug  structurally  resembles  a  natural  substrate  that  is  actively

                       transported,  then  it  is  likely  to  be  actively  transported  by  the  same  carrier
                       mechanism.  Therefore,  drugs  of  similar  structure  may  compete  for  sites  of
                       adsorption on the carrier.

                     It is a saturable process. Only a fixed number of carrier molecules are available,
                        all the binding sites on the carrier may become saturated if the drug concentration
                        gets very high.






                                                                 87
   83   84   85   86   87   88   89   90   91   92   93